Corcept Therapeutics Incorporated earnings per share and revenue

CORT earnings per share for the last quarter are 0.41 USD whereas the estimation was 0.28 USD which accounts for 45.42% surprise. Company revenue for the same period amounts to 182.55 M USD despite the estimated figure of 171.97 M USD. Estimated earnings per share for the next quarter are 0.38 USD, and revenue is expected to reach 198.02 M USD. Also watch annual changes over time to get a bigger picture of CORT earnings per share and revenue dynamics.